Accreditation for Cardiovascular Excellence (ACE) has just released the first-ever electrophysiology (EP) and Implantable Cardioverter Defibrillator (ICD) standards for accreditation. Driven by the latest available clinical evidence, the EP and ICD standards are a comprehensive review of interventional procedures in patients and adults with heart rhythm disorders.

Boston Scientific today announced that key data from 42 abstracts will be featured at the 36th Annual Scientific Sessions of the Heart Rhythm Society (HRS) in Boston on May 13-16.

Medtronic plc today announced its schedule of notable clinical studies that will be presented at Heart Rhythm 2015, the Heart Rhythm Society's 36th Annual Scientific Sessions in Boston, including two late-breaking clinical trials featuring the Evera MRI® SureScan® implantable cardioverter-defibrillator (ICD) System and Micra® Transcatheter Pacing System (TPS).

This is the month for subspecialty cardiology conferences in the U.S., with two major meetings setting anchors on each coast.

As an early career electrophysiologist, Richard I. Fogel, MD, learned to raise his hand when projects needed a captain. Now he’s CEO of the St. Vincent Medical Group in Indianapolis and president of the Heart Rhythm Society (HRS). His formula? Listen, ask good questions, surround yourself with talented people and let them do their jobs, he explains in a Q&A with Cardiovascular Business.

Medtronic  today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of two additional Attain Performa left ventricular (LV) quadripolar leads, which can be paired with the Medtronic Viva Quad XT and Viva Quad S cardiac resynchronization therapy defibrillators (CRT-D) to treat patients with heart failure. The newest additions to the Attain Performa lead portfolio, the S-shape and Straight leads, are designed to accommodate patients' varying vessel sizes and curvatures to enhance successful lead placement. Quadripolar leads (leads with four electrodes) help physicians optimize cardiac resynchronization therapy, which uses an implantable device to improve the pumping efficiency of the heart.

The Journal of the American College of Cardiology collection continues to grow with the launch of JACC: Clinical Electrophysiology, which will feature original research and review articles regarding cardiac rhythm disorders. David J. Wilber, MD, FACC, will serve as Editor-in-Chief of the new journal, which will begin publishing in March 2015 on a bimonthly basis.

Preregistration attendance for Heart Rhythm Society 2014 has increased significantly compared with last year in all demographic categories, said John D. Day, MD, chair of the scientific session program committee, with notable bumps in international physicians and allied professionals.